BioSNEDS™: The Next Generation of Nutraceutical Innovation

Circumventing Liver Degradation: The Core Benefit of BioSNEDS™.

Three Targeted Delivery Systems

Available Now

BioSNEDS™ Maximum Cellular Delivery

Coming 3rd Quarter 2024

BioSNEDS™ - BBB™ Blood - Brain Barrier Maximum Cellular Delivery

Coming 4th Quarter 2025

BioSNEDS™ - MTC™ Mitochondria

Evidence-Based Excellence: Proving BioSNEDS™ Superior Bioavailability

Explore how BioSNEDS™ revolutionizes nutraceutical bioavailability by harnessing lymphatic uptake to avoid the degrading effects of first-pass liver metabolism, breaking new ground in overcoming the bioavailability barrier.

BioSNEDS™: Bridging Pharmaceutical Innovation with Clean-Label Nutraceutical Delivery

Inspired by the efficacy of primary pharmaceutical delivery methods, BioSNEDS™ brings similar high-level delivery to nutraceuticals while strictly adhering to clean-label ingredients. This innovation represents the nutraceutical industry’s first delivery system engineered to effectively bypass the liver’s first-pass metabolism, preserving the integrity of active ingredients.

Mycofunctional™ Fermentation: Revolutionizing Bioactive Conversion

At the heart of our innovation lies our Mycofunctional Fermentation Process, a groundbreaking method transforming conventional bioactives into VN Active Nutraceutical Ingredients (ANI™). This distinctive process harnesses the power of probiotic and nutritional yeasts coupled with specially chosen medicinal mushrooms. We employ a customized fermentation system meticulously designed to encapsulate bioactive compounds within glucan particles, ensuring a more potent and bioavailable product.

Introducing BioSNEDS™
Self-Emulsifying Delivery System:

The glucan particles containing our active nutraceutical ingredients are then encapsulated into our self-emulsifying delivery system. Marking a significant leap forward, our scientifically proven delivery system enhances bioavailability by up to 10,000%. We specialize in four key areas where our system outperforms the antiquated liposomal approach:

Bioaccessibility

Our encapsulation technology protects sensitive bioactives and ensures stability far beyond what liposomal delivery can achieve.

Solubility

BioSNEDS™ guarantees complete dispersion in water, a feat often challenging for liposomal solutions.

Permeability

We enhance the absorption of bioactive compounds more effectively than traditional liposomal methods.

BioSNEDS™ is designed to improve:

Lymphatic Uptake

Engineered for optimal delivery through the lymphatic system, enhancing bioavailability and efficacy.

Bypassing Liver First-Pass Metabolism

Preserving the potency of active ingredients.

Amplified Bioavailability Achieved

Our system optimizes metabolic transport and cellular uptake, which liposomal delivery can't match.

BioSNEDS™ ingredients bypass the liver by being absorbed via the lymphatic system, setting a new standard in nutraceutical delivery. Enhanced by our specialized formulation, it moves from intestinal lymphatic vessels to the bloodstream, avoiding first-pass liver metabolism to retain its active ingredients.

Enhanced Protection with BioSNEDS™ Unique Encapsulation

BioSNEDS™ features an advanced encapsulation method that not only protects and stabilizes bioactive ingredients for extended shelf life but also minimizes any unwanted tastes and odors.

Commitment to Quality: Verdant Nature’s SGS-Certified Production

Crafted to efficiently deliver a diverse array of bioactives, BioSNEDS™ ingredients are produced in our world-class FDA-registered and SGS-certified facility. The production involves a sophisticated, low-temperature method using advanced, purpose-built equipment. This process is complemented by refined engineering methods and stringent quality control measures, ensuring the highest standard of product quality.

How BioSNEDS™ Outperforms Liposomal Delivery: Feature-by-Feature

BioSNEDS™ vs Liposomes

Self-Emulsifying Delivery Systems have been adopted by the pharmaceutical industry as the delivery system of choice to overcome the limitations of Liposomes

BioSNEDS

Liposome

Stability

Limited PMID 26410851
Increased PMID 33220429

Bioaccessibility

Limited PMID 29133217
Increased PMID 31098301

Solubility

Limited PMID 27551521
Increased PMID 3178434

Bioavailability

Limited PMID 30593772
Increased PMID 3178434

Shelf life

Limited PMID 26410851
Increased PMID 33220429

Maximize Impact with Minimal Dosage: Less is More

Substituting low bioavailability with mega doses is ineffective. There’s no sense in consuming ingredients that are 99% eliminated by the liver. BioSNEDS™ dramatically reduces the quantity needed for desired effects, enhancing product appeal and safety, making every milligram counts.

*Based on Pampa Assay or PK Study

Available in neutral- tasting, odor-free powders and emulsions, our third-party tested ingredients can easily be customized and seamlessly incorporated into existing or new product lines:

Applications:

Capsules, tablets, softgels, chewables, gummies, lozenges, melts & filmstrips

Shots, sprays, RTM & RTD beverages, functional foods

Lotions, creams, sprays, and films

Industries:

Dietary Supplements

Functional Food and Beverages

Cosmeceutical/Topicals

Pet Wellness

To learn more, book a personalized consultation with one of our experts